A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study-Reference-Cited by-同舟云学术

A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study

Published:2018-10-02 Issue:2 Volume:32 Page:173-183
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Smith Byron¹^ORCID,Cornell Lynn D.²,Smith Maxwell³,Cortese Cherise⁴,Geiger Xochiquetzal⁴,Alexander Mariam P.²,Ryan Margaret³,Park Walter⁵,Morales Alvarez Martha Catalina⁵,Schinstock Carrie⁵⁶,Kremers Walter¹⁵,Stegall Mark⁵⁷

Affiliation:

1. Department of Health Sciences Research; Mayo Clinic; Rochester MN USA

2. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA

3. Department of Laboratory Medicine and Pathology; Mayo Clinic; Scottsdale AZ USA

4. Department of Laboratory Medicine and Pathology; Mayo Clinic; Jacksonville FL USA

5. The William J von Liebig Center for Transplantation and Clinical Regeneration; Mayo Clinic; Rochester MN USA

6. Department of Internal Medicine; Division of Nephrology and Hypertension; Mayo Clinic; Rochester MN USA

7. Department of Medicine; Division of Transplantation Surgery; Mayo Clinic; Rochester MN USA

Funder

National Center for Advancing Translational Sciences

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.13340/fullpdf

Reference24 articles.

1. Through a glass darkly: seeking clarity in preventing late kidney transplant failure;Stegall;J Am Soc Nephrol,2015

2. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts;Gough;Nephrol Dial Transplant,2002

3. Reproducibility of the Banff classification in subclinical kidney transplant rejection;Veronese;Clin Transplant,2005

4. The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials;Haas;Am J Transplant,2018

5. A Coefficient of Agreement for Nominal Scales;Cohen;Educ Psychol Measur,1960

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glomerulitis in T cell-mediated renal allograft rejection and antibody-mediated rejection histology in the absence of donor-specific antibodies heralds a similar clinico-morphologic pattern of injury to an antibody-mediated rejection: A systematic review;Medical Journal Armed Forces India;2024-09

2. The Microscope and Beyond: Current Trends in the Characterization of Kidney Allograft Rejection From Tissue Samples;Transplantation;2024-08-06

3. Challenges and opportunities for designing clinical trials for antibody mediated rejection;Frontiers in Transplantation;2024-06-12

4. Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures;Transplant Immunology;2024-02

5. Automated evaluation with deep learning of total interstitial inflammation and peritubular capillaritis on kidney biopsies;Nephrology Dialysis Transplantation;2023-05-17